Clinical Trials

Showing 21-21 of 21 Results

Pediatric Oncology Trials: ANHL2121:

Phase 2 Study of Tovorafenib (DAY101) in Relapsed and Refractory Langerhans Cell Histiocytosis

Showing 21-21 of 21 Results